pentobarbital will decrease the extent or effect of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.Pentobarbital belongs to your barbiturate class of prescription drugs and generally operates primarily on the central nervous process (CNS).Its most up-to-date conclusion from November 2016 is describe